Content matching 'cell therapy approval'
Cell therapy weekly: Regulators approve autologous stem cell therapy for spinal cord injury in Japanese first
ISCT revises cell and gene therapy forecast following FDA approval of Novartis CAR-T therapy
Cell therapy weekly: First stem cell drug application approved in China for Phase II clinical trial
The first advanced therapy containing stem cells for a rare eye condition has received a positive assessment from the European Medicines Agency (EMA)
Why the FDA’s CAR-T approval sends strong signal to cell therapy industry: an interview with Martin Lamb
Latest news & views, Spotlight on immunotherapy, Spotlight on commercialization and translation, Spotlight on cell therapy regulation, Cell therapy, Industry developments, Manufacturing & scale-up
Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations”
The European Medicines Agency’s main scientific committee is recommending approval of a stem cell therapy to treat limbal stem cell deficiency. It is the first positive opinion for a stem cell therapy and the fifth for an advanced therapy medicinal product (ATMP).